Clinical trials of SALCITAL has been approved by: clinical trial registry of India (No: TRI/2012/05/002678), National institute of Medical Statistics(India Council of Medical Research). clinical Trials :gov Identifiers: NCTO1680211(A service of the U.S.National Institute Of Health). World Health Organization, International Clinical Trials Registry platform.
Salcital inhibits the α-glucosiade enzyme which stops the conversion of polysaccharide
In the intestine, Glucose Absorption is reduced
Secretion of Insulin in the Pancreas is increased
Increases the Peripheral Glucose Uptake in adipose tissues and the muscles
The active component in Salacital reticulata roots has been identified, standardized and extracted as SALCITAL, after successfully neutralizing the taste of "SALCITAL" and other herbal extracts the poly-herbal synergistic combination is blended with superior quality coffee beans sourced from coorg region of karnataka. Hence icoffee is best to manage Diabetes without compromising the authentic taste of coffee.